Growth hormone deficiency and pituitary malformation in a recurrent Cat-Eye syndrome: a family report

Ann Endocrinol (Paris). 2015 Oct;76(5):629-34. doi: 10.1016/j.ando.2015.02.002. Epub 2015 Oct 27.

Abstract

Growth hormone deficiency affects roughly between one in 3000 and one in 4000 children with most instances of growth hormone deficiency being idiopathic. Growth hormone deficiency can also be associated with genetic diseases or chromosome abnormalities. Association of growth hormone deficiency together with hypothalamic-pituitary axis malformation and Cat-Eye syndrome is a very rare condition. We report a family with two brothers presenting with growth delay due to a growth hormone deficiency associated with a polymalformation syndrome. They both displayed pre-auricular pits and tags, imperforate anus and Duane retraction syndrome. Both parents and a third unaffected son displayed normal growth pattern. Cerebral MRI showed a hypothalamic-pituitary axis malformation in the two affected brothers. Cytogenetic studies revealed a type I small supernumerary marker chromosome derived from chromosome 22 resulting in a tetrasomy 22pter-22q11.21 characteristic of the Cat-Eye syndrome. The small supernumerary marker chromosome was present in the two affected sons and the mother in a mosaic state. Patients with short stature due to growth hormone deficiency should be evaluated for chromosomal abnormality. Family study should not be underestimated.

Keywords: Cat-Eye syndrome; Déficit en hormone de croissance; Growth hormone deficiency; Malformation hypothalamo-hypophysaire; Mosaicism; Mosaïcisme; Pituitary malformation; Syndrome Cat-Eye.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Multiple / genetics
  • Aneuploidy
  • Chromosome Aberrations
  • Chromosome Disorders / diagnosis*
  • Chromosome Disorders / drug therapy
  • Chromosome Disorders / genetics
  • Chromosomes, Human, Pair 22 / genetics
  • Eye Abnormalities / diagnosis*
  • Eye Abnormalities / drug therapy
  • Eye Abnormalities / genetics
  • Hormone Replacement Therapy
  • Human Growth Hormone / deficiency*
  • Human Growth Hormone / therapeutic use
  • Humans
  • Hypothalamus / abnormalities
  • In Situ Hybridization, Fluorescence
  • Infant, Newborn
  • Karyotyping
  • Male
  • Pituitary Gland / abnormalities*

Substances

  • Human Growth Hormone

Supplementary concepts

  • Schmid-Fraccaro syndrome